👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Gerresheimer AG (GXId)

BATS Europe
Currency in EUR
81.70
0.00(0.00%)
Delayed Data
GXId Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
79.9081.70
52 wk Range
77.43109.80
Bid/Ask
81.75 / 97.30
Prev. Close
81.7
Open
79.9
Day's Range
79.9-81.7
52 wk Range
77.43-109.8
Volume
0
Average Volume (3m)
763
1-Year Change
-19.55%
Fair Value
Unlock
Fair Value Upside
Unlock
GXId Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
114.45
Upside
+40.09%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth
Show more

Gerresheimer AG Company Profile

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Employees
11913
Market
Euro Zone

Compare GXId to Peers and Sector

Metrics to compare
GXId
Peers
Sector
Relationship
P/E Ratio
24.9x41.0x−0.6x
PEG Ratio
83.22−0.270.00
Price/Book
2.0x3.1x2.6x
Price / LTM Sales
1.4x4.5x3.2x
Upside (Analyst Target)
-28.3%47.1%
Fair Value Upside
Unlock−9.0%7.1%Unlock

FAQ

What Is the Gerresheimer AG (GXId) Stock Price Today?

The Gerresheimer AG stock price today is 81.70

What Stock Exchange Does Gerresheimer AG Trade On?

Gerresheimer AG is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Gerresheimer AG?

The stock symbol for Gerresheimer AG is "GXId."

Does Gerresheimer AG Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 1.54%.

What Is the Gerresheimer AG Market Cap?

As of today, Gerresheimer AG market cap is 2.82B.

What is Gerresheimer AG Earnings Per Share?

The Gerresheimer AG EPS is 3.31.

What Is the Next Gerresheimer AG Earnings Date?

Gerresheimer AG will release its next earnings report on 12 Feb 2025.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.